STEPHANIE HIGBY: Open Payments
NPI 1588758403 · HAMILTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 61 payments from 9 companies in 2025. Trend: 2023 $2,197 · 2024 $1,947 · 2025 $1,143
Food & beverage: $1,143
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $319 |
| ABBVIE INC. | 19 | $281 |
| Novartis Pharmaceuticals Corporation | 7 | $163 |
| Janssen Biotech, Inc. | 7 | $149 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Genentech USA, Inc. | 3 | $57 |
| PFIZER INC. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Amgen Inc. | 1 | $23 |
Products named: Bimzelx, SKYRIZI, COSENTYX, TREMFYA, RINVOQ, BENLYSTA, Actemra, XELJANZ.
Industry payments across NY — which companies pay providers there.
